Evaluating Unilateral Deep Brain Stimulation in Patients With Obsessive Compulsive Disorder
NCT ID: NCT03894397
Last Updated: 2019-09-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
9 participants
INTERVENTIONAL
2019-03-26
2019-09-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In this study, the investigators will evaluate the effect of unilateral stimulation in OCD patients who currently receive bilateral BNST stimulation to treat their symptoms. We hypothesize that unilateral stimulation of the left BNST will reduce anxious and depressive symptoms, compared to no stimulation.
The study entails a double-blinded, randomized cross-over design during which every patient undergoes four stimulation conditions: stimulation of the left, right or bilateral BNST, or no stimulation. During every condition, which takes about fifteen minutes, the patient is exposed to an individually determined stimulus that normally elicits OCD-related symptoms. The patients are then asked to fill out a short questionnaire to evaluate the severity of their symptoms during the four conditions. At the end of the cross-over phase, the stimulation parameters of each patient are restored.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Unilateral Deep Brain Stimulation (DBS) of the Nucleus (Nucl.) Accumbens (Acc.) in Patients With Treatment Resistant Obsessive Compulsive Disorder (OCD)
NCT00724490
Deep-brain Stimulation in Obsessive-compulsive Disorder: Randomized, Double-blinded Clinical Trial
NCT03217123
Comparison of DBS Targets in Obsessive-compulsive Disorder
NCT01807403
Deep Brain Stimulation of the Anterior Cingulate Bundle (ACB) and the Ventral Anterior Limb of the Internal Capsule (vALIC) in Patients With Intractable Obsessive Compulsive Disorder (OCD)
NCT07303946
Long-term Follow-up in Patients With Deep Brain Stimulation (DBS) for Obsessive Compulsive Disorder (OCD).
NCT01879254
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
TRIPLE
Unblinded are: the principal investigator (who has access to all data) and the technical staff in charge of stimulation settings.
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Stimulation of left BNST
Electrical stimulation of the BNST
Electrical stimulation of the BNST
Stimulation of right BNST
Electrical stimulation of the BNST
Electrical stimulation of the BNST
Stimulation of bilateral BNST
Electrical stimulation of the BNST
Electrical stimulation of the BNST
Stimulation OFF
Electrical stimulation of the BNST
Electrical stimulation of the BNST
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Electrical stimulation of the BNST
Electrical stimulation of the BNST
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Implanted with DBS system in the bilateral BST (or max. 4mm removed from the BST outline)
* At least three months of chronic BST stimulation
* Compulsive behavior can be provoked within a clinical setting
Exclusion Criteria
* Cognitive impairment
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
KU Leuven
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kelly Luyck
PhD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Catholic University Leuven
Leuven, Vlaams-Brabant, Belgium
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
S62175
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.